Teton Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-400,000
| Closed | -$344K | – | 454 |
|
|
2019
Q4 | $344K | Hold |
400,000
| – | – | 0.03% | 374 |
|
|
2019
Q3 | $224K | Hold |
400,000
| – | – | 0.02% | 417 |
|
|
2019
Q2 | $208K | Hold |
400,000
| – | – | 0.02% | 436 |
|
|
2019
Q1 | $180K | Hold |
400,000
| – | – | 0.02% | 435 |
|
|
2018
Q4 | $192K | Hold |
400,000
| – | – | 0.02% | 428 |
|
|
2018
Q3 | $212K | Hold |
400,000
| – | – | 0.02% | 435 |
|
|
2018
Q2 | $200K | Hold |
400,000
| – | – | 0.02% | 428 |
|
|
2018
Q1 | $169K | Hold |
400,000
| – | – | 0.02% | 421 |
|
|
2017
Q4 | $152K | Hold |
400,000
| – | – | 0.01% | 401 |
|
|
2017
Q3 | $144K | Hold |
400,000
| – | – | 0.01% | 409 |
|
|
2017
Q2 | $152K | Hold |
400,000
| – | – | 0.01% | 406 |
|
|
2017
Q1 | $180K | Hold |
400,000
| – | – | 0.02% | 397 |
|
|
2016
Q4 | $152K | Hold |
400,000
| – | – | 0.02% | 377 |
|
|
2016
Q3 | $108K | Hold |
400,000
| – | – | 0.01% | 448 |
|
|
2016
Q2 | $96K | Hold |
400,000
| – | – | 0.01% | 472 |
|
|
2016
Q1 | $46K | Hold |
400,000
| – | – | ﹤0.01% | 491 |
|
|
2015
Q4 | $45K | Hold |
400,000
| – | – | ﹤0.01% | 489 |
|
|
2015
Q3 | $76K | Hold |
400,000
| – | – | 0.01% | 498 |
|
|
2015
Q2 | $280K | Hold |
400,000
| – | – | 0.02% | 448 |
|
|
2015
Q1 | $271K | Hold |
400,000
| – | – | 0.02% | 458 |
|
|
2014
Q4 | $316K | Hold |
400,000
| – | – | 0.02% | 447 |
|
|
2014
Q3 | $186K | Hold |
400,000
| – | – | 0.01% | 490 |
|
|
2014
Q2 | $200K | Hold |
400,000
| – | – | 0.01% | 497 |
|
|
2014
Q1 | $124K | Hold |
400,000
| – | – | 0.01% | 502 |
|
|
2013
Q4 | $136K | Buy |
+400,000
| New | +$483K | 0.01% | 492 |
|
Teton Advisors's GCVRZ Position: Q1 2020 in Review
Teton Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 400,000 shares — an estimated $344K sold.
Teton Advisors first reported a position in GCVRZ in Q4 2013 and held it in 25 quarters. The position peaked at $344K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Teton Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Teton Advisors sold 400,000 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $344K.
- Teton Advisors first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 25 quarters.
- Teton Advisors's Sanofi Contingent Value Rights position peaked at $344K in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Teton Advisors's 13F filing for Q1 2020, filed 14 May 2020.